![Bin Xi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bin Xi
Corporate Officer/Principal presso Zensun (Shanghai) Sci & Tech Co., Ltd.
Posizioni attive di Bin Xi
Società | Posizione | Inizio | Fine |
---|---|---|---|
Zensun (Shanghai) Sci & Tech Co., Ltd.
![]() Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01/01/2001 | - |
Storia della carriera di Bin Xi
Formazione di Bin Xi
Lanzhou University | Graduate Degree |
Statistiche
Distribuzione geografica
Cina | 3 |
Posizioni
Corporate Officer/Principal | 1 |
Graduate Degree | 1 |
Settori
Health Technology | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Zensun (Shanghai) Sci & Tech Co., Ltd.
![]() Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | Health Technology |
- Borsa valori
- Insiders
- Bin Xi
- Esperienza